1-(4-Bromophenyl)piperazine

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
353.3±27.0 °C at 760 mmHg

[ Melting Point ]:
93-94ºC

[ Molecular Formula ]:
C₁₀H₁₃BrN₂

[ Molecular Weight ]:
241.128

[ Flash Point ]:
167.5±23.7 °C

[ Exact Mass ]:
240.026199

[ PSA ]:
15.27000

[ LogP ]:
1.88

[ Vapour Pressure ]:
0.0±0.8 mmHg at 25°C

[ Index of Refraction ]:
1.575

[ Storage condition ]:
2-8°C

Click to get detail MSDS

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302 + H312 + H332

[ Precautionary Statements ]:
P280

[ Hazard Codes ]:
Xi

[ Risk Phrases ]:
20/21/22

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2933599090

Click to get detail synthetic route

Precursor

DownStream

[ HS Code ]: 2933599090

[ Summary ]:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Stability-indicating reversed-phase HPLC method development and characterization of impurities in vortioxetine utilizing LC-MS, IR and NMR.

J. Pharm. Biomed. Anal. 117 , 325-32, (2015)

The current study reports the development and validation of a stability-indicating reversed phase HPLC method for the separation and identification of potential impurities in vortioxetine, a recently ...

More Articles